CureLab Veterinary

ElenaVet®’s p62 plasmid technology is poised to revolutionize cancer treatment in dogs and cats by upregulating the body's immune system and lowering inflammation.

Print
Follow Claim My Business
Form C
View on Netcapital
Security Type
Common Stock
Min Investment
$120
Location
Dedham, MA
Offering Date
December 22, 2022
Expected Close Date
May 19, 2023
Target Raise
$10.02K-$1.23M
Security Price
$30
Valuation
$32,653,950
Website
curelabveterinary.com
Number of Employees
0
Cash
$0
Revenue
$0
Short Term Debt
$252,544
Cost of Goods
$0
Long Term Debt
$0
Net Income
$-450
Amount Raised : $113,310
Reveal the Score by Voting
＿
0
ⓘ
Business Idea
ⓘ
Business Traction
ⓘ
Management Team
ⓘ
Valuation

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment